Abstract: This invention is directed to a novel method for the inhibition of ?-glucosidase enzyme and thus treating diabetes, viral infections, fungal infections, autoimmune function disorders and obesity using compounds derived as lichen metabolites; more specifically, this includes the therapeutic applications of methylorsellinate (2,4-dihydroxy-6-methylbenzoate, Compound I), methyl-?-orinolcarboxylate (2,4-dihydroxy-3,6-dimethylbenzoate, Compound II) and zeorin (6,22-hopanediol, Compound III).
Type:
Application
Filed:
June 22, 2007
Publication date:
December 25, 2008
Applicants:
Department of Chemistry, University of Peradeniya, HEJ Research Institute
Inventors:
Vinitha Moolchand Thadani, Veranja Karunaratne, Muhammad Iqbal Choudhary